Skip to main content
. 2015 Dec 18;12:235. doi: 10.1186/s12974-015-0450-1

Table 2.

Summary of alterations in IgG1 glycosylation related to the compartment (CSF vs. serum, see also Fig. 3) and the disease (MS vs. control CSF, Fig. 4a–d, g)

Control CSF vs. control serum MS CSF vs. control CSF Peak after relapse
Afucosylation y
Bisecting GlcNAc n.s. y
Galactosylation n

y yes, n no, n.s. not significant